rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-1-15
|
pubmed:abstractText |
Persistent infection with carcinogenic human papillomavirus (HPV) causes cervical precancer (cervical intraepithelial neoplasia grade 2+) which, in the United States, is commonly treated using the loop electrical excision procedure (LEEP). Data from Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study were used to evaluate HPV persistence and reappearance after LEEP.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1055-9965
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-6
|
pubmed:dateRevised |
2009-6-26
|
pubmed:meshHeading |
pubmed-meshheading:17220326-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:17220326-Electrosurgery,
pubmed-meshheading:17220326-Female,
pubmed-meshheading:17220326-Follow-Up Studies,
pubmed-meshheading:17220326-Humans,
pubmed-meshheading:17220326-Papillomaviridae,
pubmed-meshheading:17220326-Papillomavirus Infections,
pubmed-meshheading:17220326-Precancerous Conditions,
pubmed-meshheading:17220326-Predictive Value of Tests,
pubmed-meshheading:17220326-Randomized Controlled Trials as Topic,
pubmed-meshheading:17220326-Risk Factors,
pubmed-meshheading:17220326-United States,
pubmed-meshheading:17220326-Uterine Cervical Neoplasms
|
pubmed:year |
2007
|
pubmed:articleTitle |
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
|
pubmed:affiliation |
Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. kreimera@mail.nih.gov
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|